New family therapy aims to heal grief after suicide loss
NCT ID NCT07318090
First seen Jun 27, 2026 · Last updated Jul 16, 2026 · Updated 2 times
Summary
This study is testing a family-focused therapy for families who lost a parent to suicide at least a year ago. It includes 30 families with children aged 8-14 who are struggling with prolonged grief. The therapy is done online and aims to reduce grief symptoms in both parents and children.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 30 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Dec 2025
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
8 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Parental suicide bereaved children aged 8-14 years and their parents or caregivers. * Child score of 68 or higher on the Inventory for Complicated Grief-Revised for Children (ICG-RC) and/or parent score of 5 or higher on the Brief Grief Questionnaire at phone screen and score of 30 or higher on the Inventory for Complicated Grief (ICG) at baseline. * At least 12 months after death. * Child and/or parent's primary concern is prolonged grief * Child has a biological/adoptive parent or court-appointed guardian who can present paperwork that they are able to consent for research for the youth involved in the study. Child is currently living with this caregiver and has spent most of their time in the past year under their care. * Both child and parent/caregiver have a clinical provider to communicate safety concerns (e.g., primary care provider, pediatrician) * Both child and parent/caregiver live in the United States * If taking psychoactive medications, has been on a stable dose for at least 3 months. Exclusion Criteria: Youth exclusion criteria: * Limited cognitive abilities to assent or to participate in the therapy (e.g., acute mania, psychosis, severe autism spectrum disorder) * Unstable serious medical condition * Current residence is in a state in which none of the study therapists are licensed (i.e., Alaska, Hawaii, Iowa, Louisiana, Massachusetts, Montana, New Mexico, Oregon) * Has a substance use disorder (determined by KSADS during the baseline assessment) * Is currently in therapy and unwilling to pause it for the study duration, or begins therapy during the period of study participation * Those with active suicidality (C-SSRS scores of 3 or higher) * Those who report any suicidal behaviors in the past year (i.e., suicide attempt, interrupted attempt, aborted attempt, preparatory behaviors), including any formal crisis management in the past year (e.g., presented at emergency department for suicidality), as assessed at baseline. Parent/Caregiver Exclusion criteria: * Age younger than 18 years old * Limited cognitive abilities to consent (e.g., acute mania, psychosis) * Unstable serious medical condition * For those with active suicidality (C-SSRS scores of 3 or higher), eligibility will be determined by the clinical team and PIs based on prior history of suicidality, access to lethal means, availability social support, reasons for living, and engagement in safety planning. * Those who report any suicidal behaviors in the past year (i.e., suicide attempt, interrupted attempt, aborted attempt, preparatory behaviors), including any formal crisis management in the past year (e.g., presented at emergency department for suicidality), as assessed at baseline. * Is currently in therapy and unwilling to pause it for the study duration, or begins therapy during the study duration * Current residence is in a state in which none of the study therapists are licensed (i.e., Alaska, Hawaii, Iowa, Louisiana, Massachusetts, Montana, New Mexico, Oregon) * Has a substance use disorder (determined by SCID during the baseline assessment)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Prolonged grief disorder (PGD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
2 sites. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Columbia University
New York, New York, 10032, United States
-
University of Pittsburgh
Pittsburgh, Pennsylvania, 15213, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.